ATE337002T1 - Topische behandlung zur vorbeugung von augeninfektionen - Google Patents
Topische behandlung zur vorbeugung von augeninfektionenInfo
- Publication number
- ATE337002T1 ATE337002T1 AT00961801T AT00961801T ATE337002T1 AT E337002 T1 ATE337002 T1 AT E337002T1 AT 00961801 T AT00961801 T AT 00961801T AT 00961801 T AT00961801 T AT 00961801T AT E337002 T1 ATE337002 T1 AT E337002T1
- Authority
- AT
- Austria
- Prior art keywords
- topical treatment
- eye infections
- prevent eye
- formula
- oxazolidinone antibiotic
- Prior art date
Links
- 208000001860 Eye Infections Diseases 0.000 title abstract 2
- 230000000699 topical effect Effects 0.000 title abstract 2
- 208000011323 eye infectious disease Diseases 0.000 title 1
- IZXIZTKNFFYFOF-UHFFFAOYSA-N 2-Oxazolidone Chemical compound O=C1NCCO1 IZXIZTKNFFYFOF-UHFFFAOYSA-N 0.000 abstract 2
- 230000003115 biocidal effect Effects 0.000 abstract 2
- 239000000203 mixture Substances 0.000 abstract 2
- 150000001875 compounds Chemical class 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 239000000725 suspension Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
- A61K31/541—Non-condensed thiazines containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A61K31/427—Thiazoles not condensed and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
- A61K31/454—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. pimozide, domperidone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
- A61K31/5375—1,4-Oxazines, e.g. morpholine
- A61K31/5377—1,4-Oxazines, e.g. morpholine not condensed and containing further heterocyclic rings, e.g. timolol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
- A61K31/5375—1,4-Oxazines, e.g. morpholine
- A61K31/5383—1,4-Oxazines, e.g. morpholine ortho- or peri-condensed with heterocyclic ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
- A61K47/38—Cellulose; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0048—Eye, e.g. artificial tears
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P23/00—Anaesthetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Ophthalmology & Optometry (AREA)
- Inorganic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Virology (AREA)
- Rheumatology (AREA)
- Pain & Pain Management (AREA)
- Anesthesiology (AREA)
- Immunology (AREA)
- Pulmonology (AREA)
- Dispersion Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US39461799A | 1999-09-13 | 1999-09-13 | |
| US65906300A | 2000-09-11 | 2000-09-11 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE337002T1 true ATE337002T1 (de) | 2006-09-15 |
Family
ID=27014814
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT00961801T ATE337002T1 (de) | 1999-09-13 | 2000-09-12 | Topische behandlung zur vorbeugung von augeninfektionen |
Country Status (8)
| Country | Link |
|---|---|
| EP (1) | EP1212058B1 (de) |
| JP (1) | JP2003529544A (de) |
| KR (1) | KR20020063851A (de) |
| AT (1) | ATE337002T1 (de) |
| AU (2) | AU780671B2 (de) |
| CA (1) | CA2384717C (de) |
| DE (1) | DE60030300T2 (de) |
| WO (1) | WO2001019366A1 (de) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PE20020300A1 (es) * | 2000-08-22 | 2002-05-10 | Pharmacia Corp | Composicion de solucion de un farmaco antibiotico a base de oxazolidinona con mejoramiento de la carga de farmaco |
| AR031135A1 (es) | 2000-10-10 | 2003-09-10 | Upjohn Co | Composiciones de antibiotico topico para el tratamiento de infecciones oculares |
| US20030069235A1 (en) * | 2001-09-14 | 2003-04-10 | J. Greg Slatter | Treatment for ocular infections |
| US20030096850A1 (en) * | 2001-10-11 | 2003-05-22 | Ford Charles W. | Treating infections by administration of oxazolidinones |
| EP1476135A1 (de) | 2002-02-22 | 2004-11-17 | Pharmacia Corporation | Ophthalmische formulierung mit gummi-system |
| DE102010042615A1 (de) | 2010-10-19 | 2012-04-19 | Wacker Chemie Ag | 1:1, 2:1- oder 3:1-Komplex bestehend aus einem Cyclodextrin oder Cyclodextrinderivat und einem halogeniertem Ether, seine Herstellung und seine Verwendung als Schlafmittel |
| CN108367026A (zh) * | 2015-06-18 | 2018-08-03 | 常规制药股份公司 | 抗微生物配制品 |
| EP3365022A4 (de) * | 2015-10-25 | 2019-07-24 | IVIEW Therapeutics, Inc. | Pharmazeutische formulierungen mit in-situ-gelformung |
| US11608320B2 (en) | 2020-02-02 | 2023-03-21 | Kuwait University | Oxazolidinone hydroxamic acid derivatives |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4948801A (en) * | 1988-07-29 | 1990-08-14 | E. I. Du Pont De Nemours And Company | Aminomethyloxooxazolidinyl arylbenzene derivatives useful as antibacterial agents |
| CN1546030A (zh) * | 1997-11-18 | 2004-11-17 | �������Ŷ���Լ��������˾ | 噁唑烷酮衍生物在治疗关节炎和减少癌症化学疗法毒性中的应用 |
| SK20332000A3 (sk) * | 1998-07-14 | 2001-05-10 | Pharmacia & Upjohn | Použitie oxazolidinónov |
| AR020660A1 (es) * | 1998-09-30 | 2002-05-22 | Alcon Lab Inc | Composiciones antibioticas para el tratamiento de ojos, oidos y nariz |
-
2000
- 2000-09-12 DE DE60030300T patent/DE60030300T2/de not_active Expired - Lifetime
- 2000-09-12 KR KR1020027003259A patent/KR20020063851A/ko not_active Withdrawn
- 2000-09-12 WO PCT/US2000/024914 patent/WO2001019366A1/en not_active Ceased
- 2000-09-12 AU AU73704/00A patent/AU780671B2/en not_active Expired
- 2000-09-12 CA CA2384717A patent/CA2384717C/en not_active Expired - Lifetime
- 2000-09-12 JP JP2001523000A patent/JP2003529544A/ja not_active Withdrawn
- 2000-09-12 AT AT00961801T patent/ATE337002T1/de not_active IP Right Cessation
- 2000-09-12 EP EP00961801A patent/EP1212058B1/de not_active Expired - Lifetime
-
2005
- 2005-06-30 AU AU2005202889A patent/AU2005202889B2/en not_active Expired
Also Published As
| Publication number | Publication date |
|---|---|
| KR20020063851A (ko) | 2002-08-05 |
| AU2005202889B2 (en) | 2007-09-06 |
| AU2005202889A1 (en) | 2005-07-28 |
| AU780671B2 (en) | 2005-04-07 |
| JP2003529544A (ja) | 2003-10-07 |
| AU7370400A (en) | 2001-04-17 |
| WO2001019366A1 (en) | 2001-03-22 |
| EP1212058B1 (de) | 2006-08-23 |
| CA2384717C (en) | 2010-07-27 |
| EP1212058A1 (de) | 2002-06-12 |
| DE60030300D1 (de) | 2006-10-05 |
| DE60030300T2 (de) | 2007-08-30 |
| CA2384717A1 (en) | 2001-03-22 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BG103945A (bg) | Производни на 4"-заместен-9-деоксо-9а-аза-9а- хомоеритромицин а | |
| ATE299890T1 (de) | Inhibitoren von gamma-secretase | |
| BG106825A (en) | Substituted oxazolidinones and their use in the field of blood coagulation | |
| BG103947A (en) | Derivatives of 9-oxymerythromycin | |
| BG106366A (en) | Moxifloxacin formulation containing common salt | |
| PT1030852E (pt) | Derivados de oxazolidinona e composicoes farmaceuticas | |
| ATE215952T1 (de) | Hiv-proteaseinhibitoren | |
| DE60139382D1 (de) | 2-hydroxy-mutilin-carbamat derivate und ihre anwendung als antibakterielle mittel | |
| BR9914128A (pt) | Composições antibióticas para tratamento do olho, ouvido e nariz | |
| DK0992509T3 (da) | Nye makrolid-derivater | |
| DE60030300D1 (de) | Topische behandlung zur vorbeugung von augeninfektionen | |
| WO1998006265A3 (en) | Treatment of fungal infections using a combination of an anti-fungal compound and an n-alkyl-heterocyclic compound, especially n-dodecyl-morpholine | |
| ATE203246T1 (de) | Dialkyltiacumicine | |
| AR018335A1 (es) | Compuesto carbapenico, agente antibacteriano que lo comprende y compuesto carbapenico util como intermediario para la obtencion del primero | |
| DE60026883D1 (de) | Methoden und zusammensetzungen zur behandlung von schmerzen | |
| DE69615155D1 (de) | Basische oxazolinamid-derivate von ge2270 und ge2270-änlichen antibiotika | |
| DE60005517D1 (de) | Kaliumkanal-blockierende mittel | |
| AP9801235A0 (en) | Erythromycin derivatives. | |
| WO2001032650A3 (en) | Alkaline salts of n-(6-alkyl-2,4-dioxo-1,2,3,4-tetrahydro-5-pyrimidinesulfone)-n'-isonicotinoylhydrazide, possess for their preparation, and pharmaceutical composition based on these salts | |
| PT852497E (pt) | Utilizacao de derivados de prostano e a sua combinacao com antibioticos no tratamento de infeccoes bacterianas | |
| TR199801835A2 (xx) | Antimikrobiyal kompozisyonlar. | |
| DK1232173T3 (da) | Nye fusidinsyrederivater | |
| NO20013464L (no) | Anvendelse av 3-isoksazolidinoner og hydroksylaminsyrer for behandling av infeksjoner | |
| DE69529678D1 (de) | Kombinationen von hiv-protease inhibitoren | |
| ATE286728T1 (de) | Verwendung von homocysteinderivaten zur behandlung von bakteriellen infektionen |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |